11 | APHY Financials 07/15/2014 19:29:17 Assured | Emylers | 07/15/2014 8:29:15 PM |
10 | Latest Assured Pharmacy Inc (APHY) Headlines | Stock_Tracker | 03/08/2014 8:42:37 PM |
9 | APHY 0.1798 Stock Charts $APHY 1 Month Chart | chartguy89 | 03/05/2014 10:25:36 PM |
8 | APHY Recent News Assured Pharmacy, Inc. Announces | Stock_Tracker | 03/02/2014 4:37:55 PM |
7 | APHY Stock Charts Saturday, February 22, 2014 at | chartguy89 | 02/22/2014 9:38:54 PM |
6 | APHY Stock Chart 0.19 Monday, February 10, 2014 | chartguy89 | 02/10/2014 9:51:46 AM |
5 | APHY - Assured Pharmacy Reports Results for the | SevenTenEleven | 04/04/2012 11:21:30 AM |
4 | APHY - Setting up for a move! Company | SevenTenEleven | 04/02/2012 10:08:51 AM |
3 | APHY - Assured Pharmacy to Present at Anda's 2012 | SevenTenEleven | 03/20/2012 11:14:21 AM |
2 | APHY - Uplisting to more senior exchange coming. | SevenTenEleven | 03/09/2012 10:25:11 AM |
1 | APHY - Company Website for Assured Pharmacy | SevenTenEleven | 03/02/2012 9:53:59 AM |
Recent Articles
- Transforming Housing in Canada: The Build Canada Homes Initiative
- Federal Initiative to Strengthen Housing Affordability in Canada
- Build Canada Homes: A Revolutionary Step to Affordable Housing
- Elon Musk Addresses Violence Concerns Amid Political Tensions
- Public Perception Contrasts with Trump's Economic Claims
- Apple Reinforces Design Values After Design Team Changes
- Surging Housing Market: Stocks to Watch Amid Interest Shifts
- Alto Neuroscience Investors Alerted to Participate in Case
- Nutex Health Inc. Faces Class Action: Investors Urged to Act
- X Square Robot Secures Investment for Future of Humanoid AI
- Exploring High-Yield Blue Chip Stocks: Opportunities and Risks
- Investigating Securities Violations of Lesaka Technologies, Inc.
- Potential Risks Loom as AI Stock Market Valuations Soar
- Novo Nordisk Investors Urged to Join Class Action for Compensation
- Mark Cuban Defends Steve Ballmer Amid Clippers Controversy
- Build Canada Homes Initiative Set to Revolutionize Housing Market
- Charlie Javice Takes Accountability for $175 Million Fraud Case
- Understanding the Psychological Impact of AI on Users
- Trump Engages TikTok Advocating Accountability for Media
- Understanding Economic Inequality Through Robert Reich's Lens
- Rent Surges in NYC’s Top Neighborhoods Amid Economic Shifts
- Navigating Investor Rights: Semler Scientific Case Update
- Trump Intensifies Rhetoric Against Soros Amid Controversy
- Breast Cancer Antibody Drug Conjugates: Opportunities Ahead
- Important Update for SelectQuote, Inc. Investors on Class Action
- Cornelius D. Jones Joins Prestigious Academy of Authors
- Lantheus Holdings Faces Class Action: Investors Urged to Act
- Hyundai's Supernal Faces Leadership Changes, Future Uncertain
- Larry Ellison: From College Dropout to Tech Titan
- Gold Producers Tackle Emissions with Mixed Results in ESG Metrics
- China's Potential Ban on Flush Door Handles in Cars
- Market Insights: Top 10 Large Cap Stocks Facing Declines
- Crypto Landscape Shifts: Ethereum ETFs Surge Amid Market Changes
- Investigating PACS Group, Inc.: Shareholder Concerns Addressed
- Pomerantz Law Firm Launches Investigation on Freeport-McMoRan
- Quanex Building Products Faces Potential Investor Claims Today
- Geely Automobile Holdings: Investor Concerns and Legal Steps
- MarineMax, Inc. Investors: Key Insights and Updates for HZO
- Matrix Service Company Faces Scrutiny Over Investor Claims
- Pomerantz Law Firm Investigates Potential Securities Fraud by BellRing Brands
- Bumble Inc. Faces Legal Scrutiny Over Potential Securities Violations
- Pomerantz Law Firm Launches Investigation into Agilon Health
- Pomerantz Law Firm Reviews Securities Claims Against Synopsys
- Investor Investigation: Duolingo, Inc. Faces Claims and Trends
- Insperity, Inc. Under Investigation for Possible Securities Fraud
- Class Action Filed Against Dow Inc. by Pomerantz Law Firm
- Concerns Rise as Pomerantz Law Firm Investigates Fluor Corp
- Big Week for Large-Cap Stocks: Top Gainers You Can't Miss
- Celebrating Everlight Solar: Madison's Top Choice in 2025
- Invest in Capricor Therapeutics: Upcoming Class Action Deadline